Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,571 | 938 | 99.7% |
| Education | $50.58 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,511 | 133 | $0 (2024) |
| Novo Nordisk Inc | $2,056 | 104 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,793 | 99 | $0 (2024) |
| Lilly USA, LLC | $1,760 | 85 | $0 (2024) |
| PFIZER INC. | $1,602 | 121 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $792.31 | 42 | $0 (2024) |
| Merck Sharp & Dohme LLC | $773.05 | 61 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $763.08 | 46 | $0 (2022) |
| Astellas Pharma US Inc | $430.36 | 27 | $0 (2024) |
| Gilead Sciences, Inc. | $355.03 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,238 | 106 | Lilly USA, LLC ($386.95) |
| 2023 | $1,820 | 92 | ABBVIE INC. ($444.81) |
| 2022 | $2,072 | 103 | ABBVIE INC. ($789.34) |
| 2021 | $1,857 | 108 | AbbVie Inc. ($551.62) |
| 2020 | $1,618 | 97 | AstraZeneca Pharmaceuticals LP ($290.14) |
| 2019 | $2,205 | 136 | AstraZeneca Pharmaceuticals LP ($275.18) |
| 2018 | $2,123 | 127 | PFIZER INC. ($324.68) |
| 2017 | $2,689 | 176 | Novo Nordisk Inc ($298.74) |
All Payment Transactions
945 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $29.70 | General |
| Category: Narcoplepsy | ||||||
| 12/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Biological | ||||||
| 12/12/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Hematology | ||||||
| 12/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: VACCINES | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $31.14 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Obesity | ||||||
| 10/21/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Hematology | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: PAIN | ||||||
| 10/12/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.15 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.75 | General |
| 10/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 3,697 | 4,849 | $566,938 | $196,198 |
| 2022 | 27 | 3,278 | 4,401 | $462,749 | $146,016 |
| 2021 | 27 | 3,670 | 4,880 | $487,208 | $151,147 |
| 2020 | 31 | 3,347 | 4,623 | $472,127 | $144,136 |
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 312 | 717 | $157,545 | $67,607 | 42.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 122 | 122 | $66,490 | $34,474 | 51.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 96 | 134 | $48,240 | $20,539 | 42.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 110 | 110 | $33,000 | $16,009 | 48.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 214 | 234 | $27,612 | $6,788 | 24.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 61 | 64 | $9,920 | $4,835 | 48.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 230 | 280 | $25,480 | $4,609 | 18.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 253 | 334 | $33,400 | $4,382 | 13.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 294 | 499 | $11,976 | $4,175 | 34.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 118 | 118 | $5,900 | $4,082 | 69.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 261 | 383 | $38,300 | $3,964 | 10.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 213 | 234 | $21,294 | $3,459 | 16.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 228 | 275 | $12,650 | $2,618 | 20.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 256 | 335 | $12,730 | $2,549 | 20.0% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 86 | 86 | $5,160 | $2,481 | 48.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 223 | 259 | $19,684 | $2,290 | 11.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 66 | $2,640 | $2,286 | 86.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 101 | 101 | $4,545 | $2,155 | 47.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,070 | $1,855 | 45.6% |
| 83735 | Magnesium level | Office | 2023 | 218 | 237 | $10,191 | $1,557 | 15.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 53 | 57 | $6,498 | $1,027 | 15.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 25 | 25 | $1,500 | $711.25 | 47.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 11 | 11 | $2,090 | $580.93 | 27.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 43 | 45 | $3,330 | $568.89 | 17.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 43 | 51 | $1,479 | $422.79 | 28.6% |
About Dr. Michael Mitchell, M.D
Dr. Michael Mitchell, M.D is a Internal Medicine healthcare provider based in Alexandria, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235281783.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Mitchell, M.D has received a total of $16,622 in payments from pharmaceutical and medical device companies, with $2,238 received in 2024. These payments were reported across 945 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($16,571).
As a Medicare-enrolled provider, Mitchell has provided services to 13,992 Medicare beneficiaries, totaling 18,753 services with total Medicare billing of $637,497. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Alexandria, VA
- Active Since 01/17/2007
- Last Updated 10/14/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1235281783
Products in Payments
- JARDIANCE (Drug) $947.53
- UBRELVY (Drug) $866.44
- Ozempic (Drug) $845.01
- FARXIGA (Drug) $832.26
- VRAYLAR (Drug) $762.55
- XARELTO (Drug) $669.83
- TRULICITY (Drug) $562.73
- MOUNJARO (Drug) $556.84
- SYMBICORT (Drug) $436.50
- CHANTIX (Drug) $426.82
- QULIPTA (Drug) $396.31
- SYNTHROID (Drug) $324.63
- REXULTI (Drug) $313.45
- Wegovy (Drug) $313.32
- JANUVIA (Drug) $305.85
- Saxenda (Drug) $293.32
- BREZTRI (Drug) $285.42
- Synthroid (Drug) $261.47
- ELIQUIS (Drug) $249.12
- XIFAXAN (Drug) $240.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Alexandria
Dr. Benjamin Close, M.d, M.D
Internal Medicine — Payments: $493,843
Dr. Kanna Posina, M.d, M.D
Internal Medicine — Payments: $33,667
Robert Freedman, M.d, M.D
Internal Medicine — Payments: $18,837
Wayne Wu, M.d, M.D
Internal Medicine — Payments: $18,212
Scott Whittaker, M.d, M.D
Internal Medicine — Payments: $16,235
Dr. Laura Robinette, Md, MD
Internal Medicine — Payments: $15,826